Now that the COVID-19 vaccine has arrived, health care facilities that distribute it need a way to keep it very, very cold.

The Pfizer-BioNTech vaccine introduced in the U.S. earlier this week requires an ultra-chilly storage temperature of minus 70 degrees Celsius, and a vaccine from Moderna, expected to receive Food and Drug Administration approval Friday, requires storage conditions of minus 20 degrees Celsius — more like a typical household freezer.

UPMC Children’s Hospital of Pittsburgh plans to purchase the cold-storage units needed to maintain the vaccines’ efficacy with a $250,000 grant awarded recently by the Richard King Mellon Foundation.

The money will also be used for a refrigeration trailer to transport vaccines to communities where UPMC maintains facilities, as well as for software that will allow the health care system to track vaccine recipients and make sure they receive a required follow-up dosage.

Advertise with us

“We will be immunizing citizens of the world for the next year,” said Terence Dermody, physician-in-chief and scientific director at UPMC Children’s Hospital.

“We’re incredibly grateful to the foundation for supporting these efforts.”

Dr. Dermody said the funds will cover the costs of six super-cold storage freezers.

One is likely to serve UPMC facilities in Oakland and one will be located at Children’s Hospital in Lawrenceville, he said. The other four units will be located at UPMC facilities in Harrisburg and elsewhere that UPMC has operations.

The units can be moved to other sites as needed to store vaccines before they are distributed, Dr. Dermody said.

Advertise with us

“COVID is a little like the weather in Pittsburgh,” he said. “You wait a couple days and it will change.”

The first shipment of nearly 1,000 Pfizer vaccines arrived Monday at Children’s Hospital packed in dry ice.

The hospital is using a temporary storage unit and is reviewing manufacturers from which to purchase its permanent equipment, said Dr. Dermody.

To help transport vaccines to its hospitals in smaller and rural communities, UPMC will purchase a trailer equipped with refrigeration that also keeps the vaccines at required ultra-cold temperatures.

“Think of it as an ice cream truck for vaccines,” he said.

Advertise with us

He expects 1,000 employees at UPMC Children’s Hospital to receive a vaccine by the end of December.

UPMC likely will be distributing vaccines throughout 2021 and probably into 2022.

Front-line health care workers and residents of skilled nursing facilities are the first scheduled to receive immunizations, according to state and federal guidelines.

“We’re moving as fast as we can to get people vaccinated,” said Dr. Dermody. “It’s the only safe way to put COVID-19 in the rearview mirror.”

The foundation’s grant for the cold-storage and related vaccine systems is its final gift of the year and brings its total investment in COVID-19 relief efforts to more than $33 million since the coronavirus gripped the region in March.

Advertise with us

“The goal of the foundation and its board has been to jump into this effort meaningfully — and to see it through,” said Sam Reiman, director of the city’s largest philanthropy.

Part of its COVID-19 investment is funding research about overcoming misinformation and targeted disinformation on social media about vaccines’ safety and development.

With a grant of $117,000 awarded to the University of Pittsburgh in October, researchers Jaime Sidani and Beth Hoffman are focusing their study on the Twitter social media platform.

Misinformation includes incorrect data largely related to the rapid development of the vaccines “but is not necessarily targeted or ill-intentioned,” said Ms. Hoffman, a doctoral student at Pitt’s Graduate School of Public Health.

Disinformation “is intentionally spread with the aim of doing harm,” she said, and can be targeted to groups severely impacted by the coronavirus.

Advertise with us

The women hope to identify patterns in the messaging so that as vaccines become available to more of the population, health educators can counteract it, said Ms. Sidani, assistant professor in Pitt’s division of general internal medicine.

“It’s important to do this work to promote the vaccine and basic science and help people be accepting of getting vaccinated,” said Ms. Hoffman.

The Richard King Mellon Foundation’s involvement with COVID-19 vaccine research goes back to early in the pandemic when it provided $250,000 to UPMC for clinical trials including the Moderna vaccine trial.

Mr. Reiman, 42, was among 700-plus people who volunteered to participate.

The foundation executive — who holds a master’s degree in biotechnology from Johns Hopkins University as well as a master’s in public policy and management from Carnegie Mellon University — said he was “comfortable taking this risk though it’s still a trial.”

Advertise with us

He received two doses of the vaccine and experienced arm stiffness for a few days but no other side effects.

He compared it to receiving a tetanus shot and, like all trial participants, doesn’t know if he received the vaccine or a placebo.

He continues to record information about the experience in a diary for data collection.

“I felt as a healthy adult, if I was allowed to volunteer, I could put myself into the experimental trial to help prevent potentially even more deaths,” said Mr. Reiman.

“I thought maybe it’s one more thing I could do separate from the foundation to bring this [pandemic] to an end.”

Joyce Gannon: jgannon@post-gazette.com.